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ABSTRACT
SYNTHESISAND IMMOBILIZATION OFCAPTOPRILIN HYDROGELPOLYVINYL
ALCOHOL-POLYVINYLPIRROLIDONE PREPARED BYFREEZING-THAW AND GAMMA
RADIATION. In order to apply the hydrogel as a matrix for controlled drug release, the polyvinylalcohol
(PVA)-polyvinyl pirrolidone (PVP) hydrogels have been synthesized and used for immobilization of captopril.
The mixture of PVA-PVP solution containing captopril were freezing and thawing followed by gamma
irradiation from Co-60 with the doses of 10 kGy, 20 kGy and 30 kGy. The water absorption and gel fraction
of hydrogels were measured gravimetrically. The chemical changes of hydrogels were determined using Fourier
Transform Infrared (FT-IR) spectrometer. The release of captopril were monitored using Ultra Violet-Visible
(UV-Vis) spectrophotometer. It was found that with increasing cycled of freeze-thawing and irradiation dose
up to 30 kGy, gel fraction and water absorption of hydrogels increase. FT-IR spectra demonstrated that there
was strong intermolecular crosslinking between the PVA and PVP. The release rate of captopril from hydrogel
increases with increasing irradiation dose. The release pattern indicates that the captopril released in medium
were with zero order during most of the release period and generally with burst effect. The results suggest that
crosslinked PVA-PVP hydrogels are suitable for controlled release of drug.
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ABSTRAK
SINTESIS DANIMOBILISASIKAPTOPRILPADAHIDROGELPOLIVINILALKOHOL-
POLIVINILPIRROLIDONHASILPROSESBEKU-LELEHDANIRADIASIGAMMA.Dalamupaya
aplikasi hidrogel sebagai matriks untuk pelepasan obat terkendali, telah diakukan sintesis hidrogel polivinil
alkohol (PVA)-polivinil pirrolidon (PVP) dan digunakan untuk imobilisasi kaptopril. Campuran larutan
PVA-PVP yang mengandung kaptopril dibeku-leleh yang dilanjutkan iradiasi gamma dari sumber kobalt-60
dengan dosis 10 kGy, 20 kGy dan 30 kGy. Air terserap dan fraksi gel ditentukan secara gravimetri. Perubahan
kimia hidrogel dianalisis menggunakan spektrometer Fourier Transform Infrared (FT-IR). Pelepasan kaptopril
dari media uji diukur menggunakan spektrofotometer Ultra Violet-Visible (UV-Vis). Hasil penelitian menunjukkan
bahwa dengan meningkatnya siklus beku-leleh dan dosis iradiasi hingga 30 kGy, fraksi gel dan air terserap
hidrogel meningkat. Analisis pada spektrum FT-IR menunjukkan terjadinya ikatan silang antara PVA dan PVP.
Laju pelepasan kaptopril dari hidrogel meningkat dengan meningkatnya dosis iradiasi. Pola pelepasan kaptopril
dalam media sebagai orde nol yang sebagian besar bersifat sebagai burst effect. Disimpulkan bahwa PVA-PVP
berikatan silang dapat digunakan sebagai matriks pelepasan obat terkendali.
Kata kunci: Pelepasan obat, Iradiasi, Immobilisasi, Kaptopril, PVA-PVP, Hidrogel
INTRODUCTION
Hydrogels are three-dimensional, cross-linked
networks of hydrophylic polymers. Hydrogels can be
synthesized from any hydrophylic polymer,
encompassing a wide range of chemical compositions
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and bulk physical properties. Furthermore, hydrogels
can be formulated in a variety of physical forms,
including slabs, microparticles, nanoparticles, coatings
and films. As a result, hydrogels are commonly used in
clinical practice and experimental medicine for a wide
range of applications, including tissue engineering
and regenerative medicine [1], diagnostics [2],
cellular immobilization [3], separation of biomolecules
or cells [4], and barrier materials to regulate biological
adhesions [5].
Porous structure is one the unique physical
properties of hydrogels that particular interest in
drug delivery applications The porosity of hydrogels
can easily be prepared by controlling the density of
cross-links in the gel matrix and the affinity of the
hydrogels for the aqueous environment in which they
are swollen. Their porosity also permits loading of drugs
into the gel matrix and subsequent drug release at a rate
dependent on the diffusion coefficient of the small
molecule or macromolecule through the gel network [6]..
Indeed, the benefits of hydrogels for drug delivery may
be largely pharmacokinetic-specifically that a depot
formulation is created from which drugs slowly elute,
maintaining a high local concentration of drug in the
surrounding tissues over an extended period, although
they can also be used for systemic delivery. Hydrogels
are also generally highly biocompatible, as reflected
in their successful use in the peritoneum and other sites
in vivo.
Poly(vinyl alcohol) (PVA) is hydrophylic
synthetic polymer with hydroxyl groups along its
polymer chains (Figure 1), long utilized in the form of a
hydrogel. The body tissue response to PVA gels has
been found to be mild, but they are known to undergo
calcification over time when in contact with body fluids
and thay do not have optimum mechanical properties.
Nevertheless PVA hydrogels are not of sufficient
lubrication due to the strong action hydrogen bond
formed in inner molecules. In order to improve the surface
lubrication, poly(vinyl pirrolidone) (PVP) is another
water soluble synthetic polymer (Figure 2) was
compounded with PVA. However, the combination of
PVAwith PVP can be made medical grade of hydrogels.
Freezing and thawing one of the best methods to
improve the biomedical quality of poly(vinyl alcohol)
(PVA)-polyvinylpirrolidone (PVP) blends with high
biocompatibility, high-mechanical strength and good
chemical stability [7,8]. Instead of the advantages of that
method, freezing-thaw can also be applied for
immobilization of drugs in PVA-PVP hydrogel matrix with
combination using gamma rays irradiation process to
enhance the strength, and sterility of hydrogels
simultaneously. Besides, the effect irradiation on the
drugs in the freeze state do not change significant,
caused the drugs localized inside the densed hydrogel
matrix with lower water content.
Captopril (Figure 3) is one of the most popular
drugs used for treatment hypertension as an active
inhibitor of angiotensin-converting enzyme (ACE),
shows clinical effectiveness. However, the efficacy of
captopril as a first choice of drug with antihypertensive
action after oral dosing is limited from 6 h up to 8 h.
Therefore, clinical use requires a dose of 37.5-75 mg to
be taken 3 times daily [9]. Development of a sustained
release dosage form of captopril have many advantages
to patients such as; (1) decreasing the frequency of
administration which lead to an improvement in patient
compliance and as a result clinical efficiency would be
improved; (2) it is expected that a minimization of
fluctuations in the blood concentration of the drug will
decrease the risk of side-effects [2].
On the based above descriptions, we immobilized
captopril in PVA-PVP hydrogel matrix through freezing-
thaw and followed by radiation processing
simultaneously in the aim to prepare controlled drug
release systems. The captopril release profile in the
medium was monitored using UV-Vis spectrophotometer
at 208 nm.
EXPERIMENTAL METHOD
Materials
Polyvinyl alcohol (PVA) with degree safonication
of 99 % was produced by Kuraray. Polyvinyl pirrolidone
(PVP) and Povidone 90 KF were obtained from BASF.
Figure 3. Chemical structure of captopril
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Figure 2. Chemical structure of poly(vinyl pirrolidone)
Figure 1. Chemical structure of Poly(vinyl alcohol)
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Captopril was produced by Merck. All other reagents
were pro-analytical grade and used without purification.
Instrumentation
The chemical changes of hydrogels was
characterized using Fourier Tranform Infrared (FT-IR)
Spectrophotometer (Shimadzu, Prestige-21). Captopril
released in the medium was monitored using UV-Vis
Spectrophotometer (Shimadzu). Otoclaf was used for
dissolving PVA powder. Irradiation sources from Co-60
was used to prepare hydrogels with dose rate of 7.5
kGy/h and calibrated with frieke dosimeter.
Procedure
Gel Fraction
The hydrogel samples in distilled water were
taken into shaker incubator at room temperature to
remove soluble fraction for 24 hours. The gels were dried
to constant weight under vacuum to determine the
insoluble fraction in the samples gravimetrically and was
calculated as
Gel Fraction = Wg/Wox 100 % ................. (1)
where:
Wg = The weight of dry gel after extraction
Wo = The initial weight of the gel
WaterAbsorption
The water absorption of hydrogels was
determined by gravimetry method. The gels samples were
dried in the oven at temperature of 60 oC up to constan
weight. The dried samples were then immersed in distilled
water at room temperature.The hydogels were
periodically weighed after the excess surface water was
removed with filter paper. The water absorption was
calculated as
Water absorption = (W1-Wo)/Wo x 100 % .......... (2)
where:
W1 = The weight of swollen gel at time t
Wo = The weight of the dried gels.
FT-IR Characterization
Fourier transform-infra red (FT-IR)
spectrophotometer was used to characterize the
presence of specific chemical groups in the PVA-PVP
hydrogels. FT-IR spectra were obtained over the range
of 400-4000 cm-1 (Shimadzu IR-Prestige-21 spectrometer
model 800 series). Samples were milled and mixed with
dried KBr powder placed in a sampling cup, 20 scans
were required at 2 cm-1 resolution with subtraction of the
KBr background. FT-IR spectra were also obtained for
pure PVA and PVP for comparison with the hydrogels.
Immobilization of Captopril
Eighteen grams of PVA and 12 g of PVP were
poured into 200 mL aquadest.Afterward, the mixture was
dissolved by autoclaving at 121 C for 20 minutes, then
the samples were taken out and left to cool at room
temperature. The PVA-PVP solution was poured into
7 mL vials and 50 mg captopril, homogenized and then
freezing at -15 C for 16 hours and thaw at 25 C for
8 hours 1 cycle process) respectively. The process of
freezing-thaw were repeated up to 3 cycles. The mixtures
were then irradiated using gamma rays from cobalt-60
at the doses of 10 kGy, 20 kGy and 30 kGy (dose rate
7.5 kGy/hours ). The hydrogels were taken out from the
vials, washed with water and soaked into 250 mL 0.01 N
HCl solution in beaker glass and shaked in shaker
incubator at 100 rpm at room tempeature. At a
predetermined period of the in-vitro release experiment,
5 mL aliquots of the medium was removed from the
beaker glass and the concentration of the captopril in
that aliquots was measured by using a UV-Vis
spectrophotometer (Shimadzu UV-Vis spectrophotometer
and a standard calibration curve). A 5 mL fresh 0.01 N
HCl solution was added back to beaker glass to maintain
the same total solution volume. All release studies were
carried out in triplicate. The results were presented in
terms of cumulative release as a function of time.
RESULTS AND DISCUSSION
Gel Fraction
The effect of only freeze-thaw on the gel fraction
of hydrogels are presented in Table 1. It can be seen that
with increasing freeze-thaw from 1 cycle to 3 cycles in
the preparation of hydrogel, the gel fraction of hydrogels
increases from 65.71 % to 74.88 %. It is related with the
decrease of molecular distances between PVA and PVP
in the matrix in the form of physically crosslinked as a
results of freeze-thaw. In addition, the gel fraction of
hydrogels after freeze-thaw and followed by irradiation
from 0 kGy to 30 kGy are increasing from 65.71 % to
91.17 %. It is indicated that crosslinking occurs between
PVA and PVP.
Dose (kGy)
Process (cycle)
1 2 3
0
10
20
30
65.71
81.16
86.27
87.59
68.32
82.81
86.61
89.43
74.88
83.63
87.09
91.17
Table 1. Gel fraction (%) of PVA-PVP hydrogels
prepared by freeze-thaw and irradiaton
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WaterAbsorption
The water absorption gives an indication of the
hydrophobicity or hydrophylicity of polymers. This was
evaluated using Eq.(2), and the results are shown in
Figure 4(a), 4(b), 4(c) and 4(d). From Figure 4(a), it can be
seen that water absorption of hydrogels prepared by
freeze-thaw alone increased with increasing freeze-thaw
cycles up to 3 cycles. In contrary, this phenomenon
actually uncommon occurs for the hydrogel contained
PVA alone, in which with increasing cycled freeze-thaw,
the water absorption of hydrogels decreased [10].
However, it is attributted from not all PVP molecules
effectively entrapped in the hydogel during freeze-thaw,
and when the hydrogels are exposured to medium, the
water absorption increase [11].
The effect of freeze-thaw and irradiation doses
on the water absorption of hydrogels are presented in
Figure 4(b), 4(c) and 4(d). For 10 kGy, it can be seen that
water absorption of hydrogels are increased gradually
as a function of time of immersing. But, water absorption
decreased with increasing freeze-thaw cycles. The
results suggested that the degree of crosslinking of
hydrogels increased and water diffusion restricted. With
increasing irradiation doses up to 30 kGy, the water
absorption of all hydrogels increase. It is atributtable
from PVP as hydrophylic site not incorporated into the
PVA network out of the gel (non irradiation) and with
increasing irradiaton dose crosslinks between PVA and
PVP increased [11].
In-Vitro Captopril Release from PVA-PVP
Hydrogels
The effect of time on the cumulative amounts of
captopril released from PVA-PVP hydrogels prepared by
freeze-thaw up to 3 cycles without irradiation treatment
(control) are shown in Figure 5a. It can be seen that all
hydrogels exhibite a slower rate of release and show an
initial burst release of captopril. During this burst release
within the first 4 hours, the cumulative captopril release
was 40 % for 1 cycle, 45 % for 2 cycles and 50 % for
3 cycles freeze-thaw process. Beyond the first burst
period, the release rate increases probably because
captopril located near the densed surface of the
hydrogels. Although all the hydrogels exhibited very
similar release profiles, their release rates and extends
are different. The cumulative captopril release during
the 24th study period was 63 % for 1 cycle, 68 % for
2 cycles and 72 % for 3 cycles freeze-thaw process.
The observed initial burst release is probably
due to those captopril that were located near the
hydrogel surface. Since the concentration gradient
is the driving force for captopril diffusion, high
captopril concentration gradient between the
hydrogel surface and the release medium during the
very early stage of contact leads to higher initial
Figure 4. The effect of time of immersing on the water
absorption of PVA-PVP hydrogels prepared by
combination of freeze-thaw from 1 cycle up to 3 cycles
and irradiation at the doses of : (a). 0 kGy (control),
(b). 10 kGy, (c). 20 kGy and (d). 30 kGy
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burst and fast release rate. Those captopril located near
and at surface could be released immediately from the
hydrogel to the surrounding medium as soon as the
hydrogel was placed into medium.
The release of captopril from different polymers
microsphere such as chitosan, ethyl cellulose and
sodium alginate has also been studied [12]. They found
that the captopril released during the 8 h study period
was 59 for chitosan, 62 % for ethyl cellulose, and 66 %
for sodium alginate.
Figure 5(b), 5(c) and 5(d) exhibits the cumulative
amounts of captopril released from the PVA-PVP
hydrogel prepared by combining the freeze-thawing and
irradiation. The release profiles at the doses of 10 kGy,
20 kGy and 30 kGy are similar to those control, but the
amounts of captopril release at 4 h of study period were
higher than those control for all PVA-PVP hydrogels
prepared by gamma irradiation, especially for 3 cycles
repeated freeze-thaw. For examples, 10 kGy sample had
49 %, 20 kGy had 57 %, and for 30 kGy had 62 %. It is
suggested that with increasing irradiation dose, the
crosslink between PVA and PVP increased and surface
lubricative properties of PVA-PVP hydrogels were
improved and stable [11].
FT-IR Characterization
FT-IR spectrum of pure PVA and pure PVP are
given in Figure 6. The major peak assign to PVA,
PVP and PVA-PVP are summarized in Table 2. It can be
seen that the spectrum of PVA-PVP hydrogel
(non irradiation) consisted of the functional groups
present in all two pure components. O-H (stretch) and
CH2 stretch in pure PVA, CH2 stretch, contribution from
C=O and –C in pure PVP was clearly observed in the FT-
IR spectrum for non irradiated PVA-PVP hydrogel (Figure
6). In contrary, as results of PVA blended with PVP, the
peak height of OH and C=O was decreased and
widespread when compared with the similar peaks
contributed from each polymer. It is indicated that a
hydrogen bonded occur as intermolecular interaction
between the carbonyl oxygen on a PVP chain and
a hydroxyl group along a PVA chain as shown in
Figure 7 [13,14].
Absorption (cm-1) Functional groups
PVA
2989-3766
2931
2840
1718,1469
OH stretch
CH2 strecth
CH strecth
C=O
PVP
3661
2931/2864/2738
1703
1493/1469/1440
1289/1270
754
647
OH strecth (probable)
CH and CH stretch
contribution from C-O and N-C
CH deformation of cyclic CH2 groups
amide III band (C-N stretch)
amide V band or CH2 rock
amide IV band
Table 2. Major peaks present in FT-IR spectrum of PVA and PVP
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Figure 5. Cumulative amounts of captopril released
from the PVA-PVP hydrogels prepared by freeze-thaw
up to 3 cycles and irradiated at different irradiation
doses of : (a). 0 kGy (control), (b). 10 kGy, (c). 20 kGy
and (d). 30 kGy
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Figure 7. Interchain hydrogen bonding within a PVA/PVP blend occurs
between carbonyl groups on PVP and hydroxyl groups on PVA
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When the spectrum of PVA-PVP (non irradiation)
was compared with the irradiated hydrogel (Figure 8)
there was no significant difference in peak pattern, but
there was an increased in the peak height and shifted of
position of OH and C=O towards lower frequencies.
It is indicated that crosslink occurred between PVA and
PVP as the the effect of irradiation [11].
CONCLUSION
The crosslinked PVA-PVP hydrogel was
synthesized through combination of freeze-thaw and
gamma irradiation. The number of cycle of freeze-thaw
and irradiation dose had an direct effect on gel fraction
of PVA-PVP hydrogels and inverse effect on their water
absorption.The release of captopril results correlated
with the water absorption results. The release of drug
from hydrogel is found to be dependent on the irradiation
dose. As the irradiation dose increases, drug release
increased. The results suggest that PVA-PVP crosslinked
hydrogels are suitable for controlled release of drug.
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